Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-23T20:49:16.996Z Has data issue: false hasContentIssue false
  • English
  • Français

Prolonged Progressive Multifocal Leukoencephalopathy Without Immunosuppression

Published online by Cambridge University Press:  18 September 2015

Douglas W. Zochodne  and
John C.E. Kaufmann
Douglas W. Zochodne
Affiliation:
Departments of Clinical Neurological Sciences and Pathology (Neuropathology), University Hospital, University of Western Ontario, London
John C.E. Kaufmann*
Affiliation:
Departments of Clinical Neurological Sciences and Pathology (Neuropathology), University Hospital, University of Western Ontario, London
*
Department of Pathology, Dental Sciences Building, Room 4041, The University of Western Ontario, London, Ontario, Canada N6A 5C1
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Atypical forms of progressive multifocal leukoencephalopathy (PML) may simulate other disorders. A previously healthy 70-year-old female developed unsteadiness of gait, dysarthria, dementia and weakness leading to inanition and death from bronchopneumonia over a 43 month period. The diagnosis of PML was not suspected prior to death.

Neuropathologic examination of the brain disclosed characteristic findings of PML-deep bilateral cerebral demyelinative foci with enlarged gemistocytic astrocytes and swollen oligodendrocytes containing intranuclear inclusions. Electron microscopy identified papova virus particles within these inclusions. An underlying source of immunosuppression was not identified either premortem nor at the time of autopsy.

The prolonged clinical course, simulating that of a primary degenerative disease, and the lack of apparent immunocompromise are unusual features of PML and lend credence to the suggestions that variations in its expression and course are to be expected.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 14 , Issue 4 , November 1987 , pp. 603 - 607
Copyright
Copyright © Canadian Neurological Sciences Federation 1987

References

1.Padgett, BL, Walker, DL, ZuRhein, GM, et al. Cultivation of papovalike virus from human brain with progressive multifocal leuko-encephalopathy. Lancet 1971; 1: 1257–1260.CrossRefGoogle Scholar
2.ZuRhein, GM, Chou, SM. Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965; 148: 1477–1479.CrossRefGoogle ScholarPubMed
3.Aksamit, AJ, Mourrain, P, Sever, JL, et al. Progressive multifocal leukoencephalopathy: Investigation of three cases using in situ hybridization with JC virus biotiny lated DNA probe. Ann Neurol 1985; 18: 490–496.CrossRefGoogle Scholar
4.Brooks, BR, Walker, DL. Progressive multifocal leukoencephalopathy. Neurologic Clinics 1984; 2: 299–313.CrossRefGoogle ScholarPubMed
5.Astrom, KE, Mancali, EL, Richardson, EP. Progressive multifocal leukoencephalopathy. A hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin’s disease. Brain 1958; 81: 93–111.Google ScholarPubMed
6.Richardson, EP. Progressive multifocal leukoencephalopathy. N Engl J Med 1961; 265: 815–823.CrossRefGoogle ScholarPubMed
7.Richardson, EP. Progressive multifocal leukoencephalopathy. In: Vinken, PJ, Bruyn, GW, eds. Handbook of Clinical Neurology, Volume 9, Amsterdam, North Holland 1970; 485–499.Google Scholar
8.Walker, DL. Progressive multifocal leukoencephalopathy: an opportunistic viral infection of the central nervous system. In: Vinken, PJ, Bruyn, GW, Klawans, HL, eds. Handbook of Clinical Neurology, Volume 34 Amsterdam, North Holland 1978; 307–329.Google Scholar
9.Berger, JR, Kaszovitz, B, Post, MJD, Dickinson, G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Int Med 1987; 107: 78–87.CrossRefGoogle ScholarPubMed
10.Silverman, L, Rubinstein, LJ. Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropath 1965; 5: 215–224.CrossRefGoogle ScholarPubMed
11.Stam, FC. Multifocal leuko-encephalopathy with slow progression and very long survival. Psychiat Neurol Neurochir(Amst) 1966; 69: 453–459.Google ScholarPubMed
12.Fermaglich, J, Hardman, JM, Earle, KM. Spontaneous progressive multifocal leukoencephalopathy. Neurology (Minneapolis) 1970; 20: 479–484.CrossRefGoogle ScholarPubMed
13.Bolton, CF, Rozdilsky, B. Primary progressive multifocal leukoencephalopathy. Neurology (Minneapolis) 1971; 21: 72–77.CrossRefGoogle ScholarPubMed
14.Arseni, C, Nereantiu, F. Progressive multifocal leukoencephalopathy. Europ Neurol 1971; 5: 270–280.CrossRefGoogle ScholarPubMed
15.Fans, AA, Martinez, AJ. Primary progressive multifocal leukoencephalopathy. Arch Neiirol 1972; 27: 357–360.Google Scholar
16.Rockwell, D, Ruben, FL, Winkelstein, A, et al. Absence of immune deficiencies in a case of progressive multifocal leukoencephalopathy. Am J Med 1976; 61: 433–436.CrossRefGoogle Scholar
17.Weiner, LP, Herndon, RM, Narayan, O, et al. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 1972; 286: 385–390.CrossRefGoogle ScholarPubMed
18.Knight, A, O’Brien, P, Osoba, D. ‘Spontaneous’ progressive multifocal leukoencephalopathy. Immunological aspects. Ann Intern Med 1972; 77: 229–233.CrossRefGoogle Scholar
19.Van Horn, G, Bastían, FO, Moake, JL. Progressive multifocal leukoencephalopathy: Failure of response to transfer factor and cytarabine. Neurology 1978; 28: 794–797.CrossRefGoogle Scholar
20.Kepes, JJ, Chou, SM, Price, LW. Progressive multifocal leukoencephalopathy with 10-year survival in a patient with non-tropical sprue. Neurology 1975; 25: 1006–1012.CrossRefGoogle Scholar
21.Brun, A, Nordenfeldt, E, Kjellen, L. Aspects on the variability of progressive multifocal leukoencephalopathy. Acta neuropath (Berl) 1973; 24: 232–243.CrossRefGoogle ScholarPubMed
22.Hedley-Whyte, ET, Smith, BP, Tyler, HR, et al. Multifocal leukoencephalopathy with remission and five year survival. J Neuropathol Exp Neurol 1966; 25: 107–116.CrossRefGoogle Scholar
23.Schlitt, M, Morawetz, RB, Bonnin, J, et al. Progressive multifocal leukoencephalopathy: three patients diagnosed by brain biopsy, with prolonged survival in two. Neurosurgery 1986; 18:407–414.CrossRefGoogle ScholarPubMed
24.Price, RW, Nielsen, S, Horten, B, et al. Progressive multifocal leukoencephalopathy: A burnt-out case. Ann Neurol 1983; 13: 485–490.CrossRefGoogle ScholarPubMed
25.Padgett, BL, Walker, DL. Virologie and serologic studies of progressive multifocal leukoencephalopathy. In: Sever, JL, Madden, DL, eds. Polyomaviruses and Human Neurological Disease. New York: Alan R. Liss 1983.Google Scholar
26.Peters, ACB, Versteeg, J, Bots, GTAM, et al. Progressive multifocal leukoencephalopathy. Immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol 1980; 37: 497–501.CrossRefGoogle ScholarPubMed